Search in:

Clinical Ophthalmology Volume 9, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

Laurence S Lim1 Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA;2 Vitreoretinal Department, Singapore National Eye Centre, SingaporeCorrespondence[email protected]

Wei Yan Ng2 Vitreoretinal Department, Singapore National Eye Centre, Singapore

Ranjana Mathur2 Vitreoretinal Department, Singapore National Eye Centre, Singapore

Doric Wong2 Vitreoretinal Department, Singapore National Eye Centre, Singapore

Edmund YM Wong2 Vitreoretinal Department, Singapore National Eye Centre, Singapore

Ian Yeo2 Vitreoretinal Department, Singapore National Eye Centre, Singapore

Chui Ming Gemmy Cheung2 Vitreoretinal Department, Singapore National Eye Centre, Singapore

Shu Yen Lee2 Vitreoretinal Department, Singapore National Eye Centre, Singapore

Tien Yin Wong2 Vitreoretinal Department, Singapore National Eye Centre, Singapore

Thanos D Papakostas1 Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA

Leo A Kim1 Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA

show all

Pages 1715-1718 | Published online: 16 Sep 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SchollSKirchhofJAugustinAJPathophysiology of macular edemaOphthalmologica2010224Suppl 181520714176
PubMed Web of Science ®Google Scholar
RajappaMSaxenaPKaurJOcular angiogenesis: mechanisms and recent advances in therapyAdv Clin Chem20105010312120521443
PubMed Web of Science ®Google Scholar
CheungNMitchellPWongTYDiabetic retinopathyLancet201037612413620580421
PubMed Web of Science ®Google Scholar
ZhangXBaoSHamblyBDGilliesMCVascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathyInt J Biochem Cell Biol2009412368237119646547
PubMed Web of Science ®Google Scholar
JardelezaMSMillerJWReview of anti-VEGF therapy in proliferative diabetic retinopathySemin Ophthalmol200924879219373692
PubMed Web of Science ®Google Scholar
TolentinoMJCurrent molecular understanding and future treatment strategies for pathologic ocular neovascularizationCurr Mol Med2009997398119925410
PubMed Web of Science ®Google Scholar
NguyenQDShahSMHeierJSDoDVLimJBoyerDPrimary end point (six months) results of ranibizumab for edema of the macula in diabetes (READ-2) studyOphthalmology20091162175218119700194
PubMed Web of Science ®Google Scholar
MassinPBandelloFGarwegJGSafety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes Care2010332399240520980427
PubMed Web of Science ®Google Scholar
ElmanMJAielloLPBeckRWRandomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology20101171064107720427088
PubMed Web of Science ®Google Scholar
ElmanMJBresslerNMQinHExpanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology201111860961421459214
PubMed Web of Science ®Google Scholar
MitchellPBandelloFSchmidt-ErfurthUThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology201111861562521459215
PubMed Web of Science ®Google Scholar
ArevaloJFFromow-GuerraJQuiroz-MercadoHPrimary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-upOphthalmology200711474375017398322
PubMed Web of Science ®Google Scholar
DoDVNguyenQDBoyerDOne-year outcomes of the DA VINCI study of VEGF trap-eye in eyes with diabetic macular edemaOphthalmology20121191658166522537617
PubMed Web of Science ®Google Scholar
DoDVSchmidt-ErfurthUGonzalezVHThe DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edemaOphthalmology20111181819182621546089
PubMed Web of Science ®Google Scholar
DoDVNguyenQDShahSMAn exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedemaBr J Ophthalmol20099314414919174400
PubMed Web of Science ®Google Scholar
PacellaELa TorreGImpallaraDEfficacy and safety of the intravitreal treatment of diabetic macular edema with pegaptanib: a 12-month follow-upClin Ter2013164e12123698213
PubMed Web of Science ®Google Scholar
PacellaEVestriARMuscellaRPreliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edemaClin Ophthalmol201371423142823901252
PubMedGoogle Scholar
KorobelnikJFDoDVSchmidt-ErfurthUIntravitreal aflibercept for diabetic macular edemaOphthalmology2015155225975823
PubMed Web of Science ®Google Scholar
WellsJAGlassmanARAyalaARAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med20153721193120325692915
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date